This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Louis Diorazio, PhD
Senior Principal Scientist, New Modalities at AstraZeneca
Speaker

Profile

Louis Diorazio is Senior Principal Scientist for New Modalities in AstraZeneca’s Chemical Development group based in Macclesfield UK. He obtained a BSc and PhD from Imperial College, London on aromatic fluorination followed by postdoctoral studies with Prof. Phil Magnus in the field of natural product synthesis. He has 32 years industry experience across small molecules and new modalities from discovery activities through to commercialisation. A long term feature of his activities has been driving a development culture focused on sustainable processing through training and collaboration.

Agenda Sessions

  • Rethinking Green Credentials for Oligo Manufacturing

    3:00pm